Medpace Holdings MEDP
NASDAQ MEDP
$615.11 -1.33 (-0.22%)
As of: Sep 17, 2026 · 3:59 PM EDT

Medpace Holdings (MEDP) Cash from Investing Activities (2015 - 2026)

Medpace Holdings' (MEDP) quarterly Cash from Investing Activities came in at -$23.9 million in Q2 2026, down 296.76% on a YoY basis from $12.1 million in Q2 2025, and down 253.96% quarter-over-quarter from -$6.7 million in Q1 2026.

Analysis

Medpace Holdings (MEDP) Cash from Investing Activities (2015 - 2026) Analysis & Trends

Medpace Holdings (MEDP) has reported Cash from Investing Activities for 12 consecutive years, with -$23.9 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Cash from Investing Activities fell 296.76% year-over-year to -$23.9 million; the trailing twelve-month figure through Jun 2026 stood at -$45.8 million (down 34.39% YoY), and the FY2025 full-year result was -$31.1 million, down 10.0% from the prior year.
  • Cash from Investing Activities eased to -$23.9 million in Q2 2026 per MEDP's latest filing, from -$6.7 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $2.5 million in Q1 2024 and bottomed at -$23.9 million in Q2 2026.
  • Historically, Cash from Investing Activities has averaged -$9.1 million across 5 years, with a median of -$8.9 million in 2022.
  • The sharpest annual moves came in 2024 and 2025: Cash from Investing Activities jumped 126.62% in 2024, then tumbled 494.74% in 2025.
  • Over 5 years, Cash from Investing Activities stood at -$9.2 million in 2022, then advanced by 13.26% to -$8.0 million in 2023, then grew by 5.44% to -$7.6 million in 2024, then jumped by 40.85% to -$4.5 million in 2025, then slumped by 433.98% to -$23.9 million in 2026.
  • According to Business Quant data, Cash from Investing Activities over the past three periods registered -$23.9 million, -$6.7 million, and -$4.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn -381.00 Mn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn -23.89 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn -108.34 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 28.10 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn -7.00 Mn
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn 11.09 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn -55,000.00
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn -55,941.69
10 VivoSim Labs 1.37 Mn 1.37 Mn - -23,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -23.89 Mn
Mar 31, 2026 -6.75 Mn
Dec 31, 2025 -4.47 Mn
Sep 30, 2025 -10.66 Mn
Jun 30, 2025 -6.02 Mn
Mar 31, 2025 -9.99 Mn
Dec 31, 2024 -7.56 Mn
Sep 30, 2024 -10.49 Mn
Jun 30, 2024 -12.79 Mn
Mar 31, 2024 2.53 Mn
Dec 31, 2023 -8.00 Mn
Sep 30, 2023 -8.66 Mn
Jun 30, 2023 -8.47 Mn
Mar 31, 2023 -9.50 Mn
Dec 31, 2022 -9.22 Mn
Sep 30, 2022 -7.19 Mn
Jun 30, 2022 -11.13 Mn
Mar 31, 2022 -11.21 Mn
Dec 31, 2021 -9.12 Mn
Sep 30, 2021 -6.60 Mn